ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,342,000 | -19.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,891,000 | -9.6% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,199,000 | -49.0% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $6,278,000 | -45.1% | 11,206 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $11,430,000 | -25.0% | 11,206 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $15,240,000 | -20.0% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $19,050,000 | +37.1% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $13,895,000 | -12.7% | 11,206 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,913,000 | +17.4% | 11,206 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $13,559,000 | +17.5% | 11,206 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,542,000 | -39.1% | 11,206 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $18,938,000 | – | 11,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |